Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07156136 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of IMC-P115C in Advanced PRAME-Positive Cancers

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv2
  2. Study First Submitted
Phase 1 First-in-human study of the safety and efficacy of IMC-P115C as a single agent and in combination with standard of care (SOC) agents in participants with advanced PRAME positive cancers. IMC-P115C is a half-life extended (HLE) ImmTAC targeting PRAME.
Trial Details
NCT Number NCT07156136
Lead Sponsor Immunocore Ltd
Conditions
(from sponsor)		 PRAME Positive, Cancer, HLA-A*02:01-positive
Related terms Neoplasms
Enrollment 140 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov